AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
- Cochlear trades below historical valuation levels
- JB Hi-Fi stock reflects strong price growth from 52-week low
- Both companies offer unique positioning within their industries
Two of Australia’s established names, Cochlear Ltd (COH) and JB Hi-Fi Ltd (JBH), continue to draw investor attention as 2025 progresses. With one a global leader in hearing technology and the other a dominant retailer in electronics, both companies offer insights into market sentiment and sector dynamics within the ASX200.
Cochlear (ASX:COH): A Pioneer in Hearing Solutions
Cochlear Ltd, headquartered in Sydney and founded in 1981, specializes in designing and manufacturing implantable hearing solutions. The company’s portfolio includes three distinct implant types tailored to different medical needs. With a presence in over 50 countries and more than 5,000 employees, Cochlear has successfully delivered over 750,000 devices globally.
In 2025, the share price of Cochlear has edged up by 0.3%. When examining its valuation, the stock currently trades at a price-to-sales (P/S) ratio of 8.62x, slightly below its 5-year average of 9.18x. This may reflect a potential undervaluation, especially considering the company’s consistent revenue growth over the past three years. This metric, while only one lens of evaluation, indicates that Cochlear shares are currently valued more modestly compared to historical norms — a point worth noting for followers of ASX200.
JB Hi-Fi (ASX:JBH): Electronics Retailer with Market Momentum
Founded in 1974, JB Hi-Fi Ltd is a leading name in the consumer electronics and entertainment retail market. It operates across three main segments: JB Hi-Fi Australia, JB Hi-Fi New Zealand, and The Good Guys. The company is recognized for its cost-leadership model, focusing on competitive pricing and frequent promotional offers that appeal to value-driven shoppers.
As of now, the JB Hi-Fi share price has surged 80.8% from its 52-week low — a significant rebound highlighting positive investor sentiment. Currently, the stock trades at a P/S ratio of 1.24x, well above its 5-year average of 0.70x. This elevated valuation may reflect strong market performance and consumer demand across its product categories.
Both Cochlear and JB Hi-Fi remain prominent in their respective sectors, with Cochlear’s consistent revenue growth and strategic global footprint, and JB Hi-Fi’s strong retail strategy and market gains in 2025. As part of the ASX200, these companies continue to play a significant role in shaping Australia's equity landscape and are worth tracking for insights into their industries’ broader trends.
